ArticleThe Plant journal : for cell and molecular biology2026
Discovery of pseudobaptigenin synthase in fungal-infected Trifolium pratense roots.
Article in The Plant journal : for cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Pterocarpans are structurally complex defense compounds produced by legumes (Fabaceae). They are commonly associated with antimicrobial activity and thought to be synthesized de novo or accumulated in response to microbial pathogens. (-)-Maackiain is a lineage-specific pterocarpan detected in some legumes, including red clover (Trifolium pratense). The biosynthesis of (-)-maackiain involves the formation of a distinctive methylenedioxy bridge to convert calycosin to pseudobaptigenin, which is predicted to be catalyzed by a cytochrome P450. We integrated metabolomic and transcriptomic datasets of T. pratense roots treated with the fungal pathogens, Fusarium oxysporum (hemibiotroph) and Phoma medicaginis (necrotroph), to identify candidate P450 genes associated with pterocarpan accumulation. Fungal elicitation initiated a robust defense response via upregulation of core metabolism and over 30 isoflavonoid-associated genes, including both early (chalcone-flavanone) and late (pterocarpan) biosynthetic modules. These transcriptomic changes were accompanied by drastic pathogen-specific divergence in metabolic profiles, featuring over 40 differentially accumulated (iso)flavonoids. F. oxysporum infection resulted in severe necrosis and markedly greater transcriptional reprogramming relative to P. medicaginis. However, the defense response to P. medicaginis was characterized by the strong accumulation of pterocarpans, including (-)-maackiain. Using a combination of strategies, including weighted gene co-expression network analysis, candidate cytochrome P450s were selected for putative pseudobaptigenin synthase (PbS) activity. Functional characterization using biotransformation and microsomal fraction assays identified T. pratense pseudobaptigenin synthase (TpPbS/CYP76F319), which catalyzes the conversion of calycosin to pseudobaptigenin. This discovery facilitates the reconstitution of (-)-maackiain biosynthesis and its future heterologous production at scale for agricultural and health applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.